Andrew Dunn

Andrew Dunn has a diverse professional background in scientific research and management, currently serving as a Gardener at Gardening Leave since July 2025. Prior to this role, Andrew held the position of Director at CRISPR Therapeutics from March 2017 to July 2025 and was a Senior Scientist at Veritas Genetics and PCLS, with responsibilities including the re-launch of Predictive Biosciences. Previous experience includes serving as a Scientist at N-of-One Therapeutics and Predictive BioSciences. Andrew holds a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology from the University of Vermont and a Bachelor of Arts in Biology from Colorado College.